Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...
The MarketWatch News Department was not involved in the creation of this content. -- Real-World Implementation: Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in ...
Since the 1990s, a race-based method for assessing kidney function placed many Black patients lower on the transplant waitlist. However, thousands of these patients were moved up the list in recent ...
Hosted on MSN
Innovate Corp. stock soars on FDA approval
Investing.com -- Shares of Innovate Corp. (NYSE:VATE) surged 60% following the announcement that the U.S. Food and Drug Administration (FDA) has approved the company's MediBeacon Transdermal GFR ...
Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...
CLEVELAND, Ohio— Until July, if you were Black, your kidney function was likely assessed differently than everyone else. Not any longer. Researchers have eliminated race as a factor in assessing ...
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback